BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 19414397)

  • 1. Pro-apoptosis and anti-proliferation effects of a recombinant dominant-negative survivin-T34A in human cancer cells.
    Shen C; Liu W; Buck AK; Reske SN
    Anticancer Res; 2009 Apr; 29(4):1423-8. PubMed ID: 19414397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-level expression, purification and pro-apoptosis activity of HIV-TAT-survivin (T34A) mutant to cancer cells in vitro.
    Ma X; Zheng W; Wei D; Ma Y; Wang T; Wang J; Liu Q; Yang S
    J Biotechnol; 2006 May; 123(3):367-78. PubMed ID: 16406157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction, expression, and purification of HIV-TAT-survivin (T34A) mutant: a pro-apoptosis protein in Escherichia coli.
    Ma X; Zheng W; Wei D; Ma Y; Wang T; Wang J; Liu Q; Yang S
    Protein Expr Purif; 2006 May; 47(1):36-44. PubMed ID: 16260148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triplex-forming oligodeoxynucleotides targeting survivin inhibit proliferation and induce apoptosis of human lung carcinoma cells.
    Shen C; Buck A; Polat B; Schmid-Kotsas A; Matuschek C; Gross HJ; Bachem M; Reske SN
    Cancer Gene Ther; 2003 May; 10(5):403-10. PubMed ID: 12719710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procaspase 3 expression in ovarian carcinoma cells increases survivin transcription which can be countered with a dominant-negative mutant, survivin T34A; a combination gene therapy strategy.
    McKay TR; Bell S; Tenev T; Stoll V; Lopes R; Lemoine NR; McNeish IA
    Oncogene; 2003 Jun; 22(23):3539-47. PubMed ID: 12789262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Survivin on cell proliferation and apoptosis in MG-63 cells in vitro.
    Liang X; Da M; Zhuang Z; Wu W; Wu Z; Wu Y; Shen H
    Cell Biol Int; 2009 Jan; 33(1):119-24. PubMed ID: 18996209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COX-independent antineoplastic effects of sulindac in oral cancer are mediated by survivin down-regulation.
    Scheper MA; Sauk JJ; Nikitakis NG
    Anticancer Res; 2006; 26(6B):4103-13. PubMed ID: 17201121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preparation of recombinant HIV-TATm-survivin (T34A) protein and its pro-apoptosis activity to cancer cells in vitro].
    Zheng WY; Ma XY; Wei DZ; Wang JZ; Liu QH; Ma YS; Yang SL
    Sheng Wu Gong Cheng Xue Bao; 2006 Mar; 22(2):285-92. PubMed ID: 16607958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen inhibits proliferation and induces apoptosis in human hepatocellular carcinoma cell line HepG2 via down-regulation of survivin expression.
    Guo R; Huang Z; Shu Y; Jin S; Ge H
    Biomed Pharmacother; 2009 Jun; 63(5):375-9. PubMed ID: 18993026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
    Shan BE; Wang MX; Li RQ
    Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation-induced apoptosis of tumor cells is facilitated by inhibition of the interaction between Survivin and Smac/DIABLO.
    Ogura A; Watanabe Y; Iizuka D; Yasui H; Amitani M; Kobayashi S; Kuwabara M; Inanami O
    Cancer Lett; 2008 Jan; 259(1):71-81. PubMed ID: 17967504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of melanoma cell apoptosis and inhibition of tumor growth using a cell-permeable Survivin antagonist.
    Yan H; Thomas J; Liu T; Raj D; London N; Tandeski T; Leachman SA; Lee RM; Grossman D
    Oncogene; 2006 Nov; 25(52):6968-74. PubMed ID: 16702945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Terminally differentiated neutrophils predominantly express Survivin-2 alpha, a dominant-negative isoform of survivin.
    Hu H; Shikama Y; Matsuoka I; Kimura J
    J Leukoc Biol; 2008 Feb; 83(2):393-400. PubMed ID: 17965335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning, expression, and purification of the recombinant pro-apoptotic dominant-negative survivin T34A-C84A protein in Escherichia coli.
    Tsai SL; Chang YC; Sarvagalla S; Wang S; Coumar MS; Cheung CHA
    Protein Expr Purif; 2019 Aug; 160():73-83. PubMed ID: 31004782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genistein synergizes with RNA interference inhibiting survivin for inducing DU-145 of prostate cancer cells to apoptosis.
    Yuan-Jing F; Nan-Shan H; Lian X
    Cancer Lett; 2009 Nov; 284(2):189-97. PubMed ID: 19433345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of survivin for radiation therapy. Prognostic and predictive factor and therapeutic target.
    Capalbo G; Rödel C; Stauber RH; Knauer SK; Bache M; Kappler M; Rödel F
    Strahlenther Onkol; 2007 Nov; 183(11):593-9. PubMed ID: 17960333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of cooking oil fumes exposure with lung cancer: involvement of inhibitor of apoptosis proteins in cell survival and proliferation in vitro.
    Hung HS; Wu WJ; Cheng YW; Wu TC; Chang KL; Lee H
    Mutat Res; 2007 Apr; 628(2):107-16. PubMed ID: 17229588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survivin: a new target for anti-cancer therapy.
    Ryan BM; O'Donovan N; Duffy MJ
    Cancer Treat Rev; 2009 Nov; 35(7):553-62. PubMed ID: 19559538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect on apoptosis and cell cycle of recombinant double negative dominant mutation Survivin (T34/117A) in breast cancer cell B-Cap-37.
    Wang L; Kang Y; Zheng W; Li L; Shi L; Ma X
    Biomed Pharmacother; 2014 Apr; 68(3):277-84. PubMed ID: 24513056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of ERK, Bcl-2 family and caspase 3 in recombinant human activin A-induced apoptosis in A549.
    Wang B; Feng Y; Song X; Liu Q; Ning Y; Ou X; Yang J; Zhang X; Wen F
    Toxicology; 2009 Apr; 258(2-3):176-83. PubMed ID: 19428937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.